##plugins.themes.vojs.article.sidebar##

PDF (Tiếng Việt)
Published: 2025-08-22
Abstract Views: 15
Views PDF (Tiếng Việt): 5
Issue
Vol. 18 No. 2 (2025)
Section
Research

EMERGENCY MANAGEMENT OF PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA IN NEWBORNS: INSIGHTS FROM THREE RARE CLINICAL CASES

Van Chien Nguyen1, Ngoc Anh Tuan Hoang1, Duc Toan Nguyen1, El Eban H1, Thi Thuy Linh Vu2
1 Tay Nguyen Regional General Hospital
2 Tay Nguyen University

##plugins.themes.vojs.article.main##

Abstract

Supraventricular tachycardia (SVT) is a common arrhythmia in neonates. Most SVT in the neonate is due to a re-entrant mechanism. SVT may initially be asymptomatic, but when prolonged it may result in congestive cardiac failure and shock after a variable period. The efective treatment of any arrhythmia requires attention to overall hemodynamic status and the mechanism of arrhythmia. The present study reports three cases of neonatal patients were referred to our department with tachycardia and hemodynamic instability. Although there are still many limitations in treatment (the frst-line drug as Adenosine, ...), but we have successfully treated it with available resources at the our hospital. In this report, the authors present the clinical, paraclinical and outcomes features of neonatal arrhythmias with review of the literature.

##plugins.themes.vojs.article.details##

Keywords

supraventricular tachycardia, cardioversion, newborn

References

1. Barton AL, Mofett BS, Valdes SO et al. Efcacy and safety of high-dose propranolol for the management of infant supraventricular tachyarrhythmias. J Pediatr 2015;166 (1):115-118. https://doi.org/10.1016/j.jpeds.2014.08.067
2. Ciriello GD, Colonna D, Papaccioli G et al. Triple Antiarrhythmic Therapy in Newborns with Refractory Atrioventricular Reentrant Tachycardia. Pediatr Cardiol 2023;44(5):1040-1049. https://doi.org/10.1007/s00246-023-03162-5
3. Deal BJ, Keane JF, Gillette PC et al. Wolf-Parkinson-White syndrome and supraventricular tachycardia during infancy: management and follow-up. J Am Coll Cardiol 1985;5(1):130-135. https://doi.org/10.1016/S0735-1097(85)80095-4
4. Hornik Christoph P, Chu Patricia Y, Li Jennifer S et al. Comparative Efectiveness of Digoxin and Propranolol for Supraventricular Tachycardia in Infants. Pediatric Critical Care Medicine 2014;15(9):839-845. https://doi.org/10.1097/pcc.0000000000000229
5. Pacifci GM. Clinical Pharmacology of Digoxin in Infants and Children Clin Med 2021;3(2):25-32.
6. Quattrocelli A, Lang J, Davis A et al. Age makes a diference: Symptoms in pediatric supraventricular tachycardia. J Arrhythm 2018;34(5):565-571. https://doi.org/10.1002/joa3.12103
7. Sanatani S, Potts JE, Reed JH et al. The study of antiarrhythmic medications in infancy (SAMIS): a multicenter, randomized controlled trial comparing the efcacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants. Circ Arrhythm Electrophysiol 2012;5(5):984-991. https://doi.org/10.1161/circep.112.972620
8. Singh HR, Garekar S, Epstein ML et al. Neonatal Supraventricular Tachycardia (SVT). NeoReviews 2005;6(7):e339-e350. https://doi.org/10.1542/neo.6-7-e339
9. Smith S. Advanced Paediatric Life Support: A Practical Approach to Emergencies, 7th edition, Wiley-Blackwell, 2023.